Lucid Diagnostics Net Income Growth & History (LUCD)
Lucid Diagnostics's net income was −$58.0M for fiscal 2025.
View full Lucid Diagnostics company overviewLucid Diagnostics annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$58.0M | −$12.5M | — |
| 2024 | 2024-12-31 | −$45.5M | $7.1M | — |
| 2023 | 2023-12-31 | −$52.7M | $3.5M | — |
| 2022 | 2022-12-31 | −$56.2M | −$28.1M | — |
| 2021 | 2021-12-31 | −$28.1M | −$19.8M | — |
| 2020 | 2020-12-31 | −$8.3M | — | — |
Lucid Diagnostics quarterly net income
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$11.7M | −$7.2M | — |
| Q1 2026 | 2026-03-31 | −$13.9M | $13.0M | — |
| Q4 2025 | 2025-12-31 | −$16.3M | −$4.7M | — |
| Q3 2025 | 2025-09-30 | −$10.4M | $2.0M | — |
| Q2 2025 | 2025-06-30 | −$4.4M | $6.6M | — |
| Q1 2025 | 2025-03-31 | −$26.9M | −$16.3M | — |
| Q4 2024 | 2024-12-31 | −$11.5M | −$711,000 | — |
| Q3 2024 | 2024-09-30 | −$12.4M | $1.8M | — |
| Q2 2024 | 2024-06-30 | −$11.0M | $376,000 | — |
| Q1 2024 | 2024-03-31 | −$10.6M | $5.6M | — |
| Q4 2023 | 2023-12-31 | −$10.8M | $4.1M | — |
| Q3 2023 | 2023-09-30 | −$14.2M | $141,000 | — |
| Q2 2023 | 2023-06-30 | −$11.4M | $3.2M | — |
| Q1 2023 | 2023-03-31 | −$16.2M | −$4.0M | — |
| Q4 2022 | 2022-12-31 | −$14.9M | −$3.6M | — |
| Q3 2022 | 2022-09-30 | −$14.3M | −$7.4M | — |
| Q2 2022 | 2022-06-30 | −$14.6M | −$8.5M | — |
| Q1 2022 | 2022-03-31 | −$12.3M | −$8.6M | — |
| Q4 2021 | 2021-12-31 | −$11.3M | — | — |
| Q3 2021 | 2021-09-30 | −$7.0M | −$4.9M | — |
| Q2 2021 | 2021-06-30 | −$6.2M | — | — |
| Q1 2021 | 2021-03-31 | −$3.7M | — | — |
| Q3 2020 | 2020-09-30 | −$2.0M | — | — |
Lucid Diagnostics net income trends
Over the last five fiscal years, Lucid Diagnostics's net income decreased from −$8.3M to −$58.0M, a change of −$49.7M. The latest reported quarter, Q2 2026, shows −$11.7M.
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lucid Diagnostics source filings ↗Community posts
Lucid Diagnostics receives Medicare payments and closes $15 million financing
Lucid Diagnostics ($LUCD) said it has begun receiving Medicare reimbursement for its EsoGuard esophageal cancer test at the established rate of $1,938.01 per test. The announcement advances the reimbursement story from submission of claims ...